Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1543 USD | +0.88% | +3.56% | +10.21% |
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.63% |
Latest transcript on Elite Pharmaceuticals, Inc.
1 day | +0.88% | ||
1 week | +3.56% | ||
Current month | -6.43% | ||
1 month | -2.65% | ||
3 months | +9.59% | ||
6 months | +68.63% | ||
Current year | +10.21% |
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.1543 | +0.88% | 500 606 |
24-03-27 | 0.153 | +0.43% | 170,933 |
24-03-26 | 0.1524 | +0.36% | 352,404 |
24-03-25 | 0.1518 | +0.40% | 1,698,465 |
24-03-22 | 0.1512 | -1.08% | 209,759 |
Delayed Quote OTC Markets, March 28, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+10.21% | 156M | |
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
+0.55% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.14B |